Price Monitoring Extension | 24-Aug-2022 | 14:00 | RNS |
Second Price Monitoring Extn | 24-Aug-2022 | 11:06 | RNS |
Price Monitoring Extension | 24-Aug-2022 | 11:00 | RNS |
Second Price Monitoring Extn | 24-Aug-2022 | 09:05 | RNS |
Price Monitoring Extension | 24-Aug-2022 | 09:00 | RNS |
Trading update | 24-Aug-2022 | 07:00 | RNS |
Result of AGM | 26-Jul-2022 | 12:31 | RNS |
Commercial and scientific update | 20-Jul-2022 | 07:00 | RNS |
Joint development agreement signed with Firmenich | 11-Jul-2022 | 07:00 | RNS |
Director Appointment and Director Dealing | 01-Jul-2022 | 07:00 | RNS |
Final Results | 28-Jun-2022 | 07:00 | RNS |
ProBiotix Health - Appointment of CEO | 20-Jun-2022 | 07:00 | RNS |
Admission of ProBiotix Health plc to AQSE | 31-Mar-2022 | 07:01 | RNS |
Director/PDMR Shareholding | 25-Mar-2022 | 14:36 | RNS |
Price Monitoring Extension | 18-Mar-2022 | 14:00 | RNS |
Currency | UK Pounds |
Share Price | 16.57p |
Change Today | 0.071p |
% Change | 0.43 % |
52 Week High | 39.00 |
52 Week Low | 6.00 |
Volume | 17,869 |
Shares Issued | 97.94m |
Market Cap | £16.23m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:10 | 533 @ 16.00p |
10:09 | 1,838 @ 16.60p |
09:14 | 15,000 @ 16.01p |
08:07 | 120 @ 16.00p |
08:07 | 240 @ 16.67p |
CEO | Stephen O'Hara |
Finance Director | Graham Myers |
You are here: research